Reuters logo
BRIEF-Sangamo Therapeutics enters into amended and restated agreement with Cowen and Company
2017年5月26日 / 晚上9点47分 / 6 个月前

BRIEF-Sangamo Therapeutics enters into amended and restated agreement with Cowen and Company

May 26 (Reuters) - Sangamo Therapeutics Inc

* On May 26 co entered into amended and restated at-market offering program sales agreement with Cowen and Company

* Co may issue and sell from time to time up to $75.0 million of common stock, par value $0.01 per share, through Cowen as sales agent

* Amended sales agreement amends and restates in its entirety and supersedes sales agreement dated December 7, 2016 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below